¤³¤Î¥Ú¡¼¥¸¡Ê°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©¡ËÆâ¤Î¥¹¥­¥Ã¥×¥á¥Ë¥å¡¼
  1. ¥µ¥¤¥È¤Î¥á¥¤¥ó¥á¥Ë¥å¡¼¤Ø°Üư
  2. ¥µ¥¤¥È¤Î¥æ¡¼¥¶¥á¥Ë¥å¡¼¤Ø°Üư
  3. ¤³¤Î¥Ú¡¼¥¸¡Ê°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©¡Ë¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ø°Üư

°Ê²¼¡¢¤³¤Î¥Ú¡¼¥¸(°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©)¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ç¤¹¡£

¥³¥ß¥å¥Ë¥Æ¥£¡§
°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©¡Ê¤´¶á½ê¤Î³¹¥Í¥¿¡Ë

°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©
¥²¥¹¥È ºß¸½ÂåÃËÀ­ÊÝ·ò»Ô¾ìÃæ¡¤ÔãÍÛé»ÖáÀ®°Ù°Ý»ý¼«¿®çпÆÌ©À¸³èŪ½ÅÍ×Êå½õ產ÉÊ¡£Â¶Ã桤°ìßÜÅþŷμÔãÍÛé»ÀµÉÊçаҼ©¹Ý¡ÊViagra¡ËÀ§ºÇ¾ïÈïÆ¤ÏÀŪÑÀÂçÁªÚ¤¡£Á°¼Ô°ÊÅ·Á³ÁðËÜÇÛÊýÃøãÊ¡¤¶¯Ä´»ýµ×ÂÑÎÏçÐñó¼ÁÄ´Íý¡¨¸å¼Ô§À§Á´µåºÇÁá³Í FDA ³Ë½ÚŪ PDE5 ÍÞÀ©Ñý¡¤¼çÂÇ¨Úø«¹Å¡£ËÜʸÕò·ë¹çÕó¶ÈîÐÕÜÃμ±çÐÜÞ°ÒÚËÚ¡¡¤Ê¬ÀÏÑÀ¼Ôºßé»Íý¡¢Úò̡¢»ýåô»þ´ÖçаÂÁ´À­¾åŪº¹°Û¡¤幫½õÃËÀ­ÁªÚ¤ºÇŬ¹ç¼«¸ÊŪÊý°Æ¡£







°ì¡¢é»ÍýºîÍÑÈæ³Ó¡§Å·Á³ÁðËÜ vs Î×¾²À¾é»
°Ò¼©¹Ý¡ÊViagra¡ËÀ®Ê¬°Ù¡ÖÀ¾ÃÏÆáÈó¡ÊSildenafil¡Ë¡×¡¤Ö¤±÷ PDE5 ÍÞÀ©Ñý¡£ÕàǽÍÞÀ© cGMP ʬ²ò¡¤»È±¢è³³¤ÌÊñó·ì´Éаĥ¡¢·ìήùá²Ã¡¤ºßÀ­»É·ã²¼Ã£ÅþËÖµ¯¡£º¬Ú¡¡ÔThe Journal of Urology, 2018¡ÕÅý·×¡¤ÉþÍѰҼ©¹ÝŪÃËÀ­Ã桤Ìó 70–80% ǽÀ®¸ùãÅþËÖµ¯¸ùǽ²þÁ±¡¤Ìà¶ÕôÃæÏ·Ç¯ÃËÀ­ÚòÌÌÀðý¡£

ÁêÈæÇ·²¼¡¤°ìßÜÅþŷμÀµÉʼçÍ×ͳ¿¼ïÁðËÜÀ®Ê¬ÁÈÀ®¡¤ÎãÇ¡¿ÍÒÔ¡¢¼¯Âû¡¢°üÍÓ藿¡¢Ç÷áÅ·¡¢êµÁðÅù¡£¸¦µæðý¼¨¡¤¿ÍÒÔ¡ÊGinseng¡Ë²ÄðýÃøÄó¹â·ìÀ¶âÐ酮¿åÊ¿¡¤²þÁ±±¢è³ËÖµ¯¸ùǽ¡Ê¡ÔJournal of Ethnopharmacology, 2019¡Õ¡Ë¡¤¼©°üÍÓ藿ÃæÅª³èÀ­À®Ê¬ icariin ¶ñÍ­ PDE5 ÍÞÀ©³èÀ­¡¤Õô²þÁ±Áá±ÌϱäĹ»ýµ×ÎÏÍ­Êå½õºîÍÑ¡£

åÁ·ëÕôÈæ¡§

°Ò¼©¹Ý ¢ª é»ÍýľÀÜ¡¤ºîÍѿ׮

°ìßÜÅþŷμ ¢ª ÁðËÜÄ´Íý¡¤Ä¹´ü²þÁ±À­¸ùǽ



Æó¡¢ÚòÌçлýåô»þ´Ö¡§Â¨Úàvs »ýµ×
°Ò¼©¹ÝÉþÍѸåÄ̾ï 30–60 ʬ¾âµ¯Úá¤é»Úòİݻý Ìó 4–6 ¾®»þ¡£Õô±÷¶ö¼¤À­À¸³è¼ûµá°¿ËÖµ¯¸ùǽ¾ã㨡ÊED¡Ë´µ¼Ô¡¤À§Èó¾ïÍ­ÚÃŪ¨»þ½õËÖÊý°Æ¡£

¼© °ìßÜÅþŷμÔãÍÛé»ÀµÉʶ¯Ä´ Ĺ´üÄ´Íýçлýµ×ÂÑÎÏ¡¤»ÈÍѼԲóñ¿»Ø½Ð¡¤»ýåôÉþÍÑ 1–2 ½µ¸å¡¤±¢è³ËÖµ¯¹ÅÅÙùá²Ã¡¤À­ÂÑÎÏÌÀðý²þÁ±¡¤Í­»þ¿Ó»êǽ¡Ö³ÖÆü°ÍçÑÍ­´¶¡×¡£º¬Ú¡¡ÔPhytotherapy Research, 2020¡ÕÊó¹ð¡¤´ÞÍ­ icariin ŪÁðËÜÇÛÊýºß±äĹÀ­À¸³è»þ´ÖÏÂÄó¾£ËÖµ¯¹ÅÅÙÊýÌÌÚòÌðýÃø¡£

ÕôÈæ·ëÏÀ¡§

°Ò¼©¹Ý ¢ª û´üÇúâ¤Î϶¯

°ìßÜÅþŷμ ¢ª Ĺ´ü»ýµ×¡¤ñó¼Á²þÁ±ÌÀðý

»°¡¢°ÂÁ´À­çÐÉûºîÍÑ¡§é»Úö¯ÅÙ vs ÁðËÜ溫ÏÂ

°Ò¼©¹ÝÉûºîÍÑÊñ³çƬÚô¡¢çÀĬ¹È¡¢»ëë´ÌϸҰ¿¿´Ø©¡¤Ìà¶¿´·ì´É¼ÀÉ´µ¼Ô¹¹¼û¶à¿µ¡Ê¡ÔCirculation, 2017¡Õ¡Ë¡£º¡³°¡¤çо˻ÀóÅÎàé»ÊªÆ±ÉþÐò¤À®Äã·ìÔÚÉ÷𪡣

°ìßÜÅþŷμÔãÍÛé»ÀµÉÊÁðËÜÇÛÊýÉûºîÍѳÓÄ㡤â»Ô¾ì¾å¸ºß仿ËÁÉÊ¡¤Éôʬ²Äǽ´Þ̤ɸ¼¨ÅªÀ¾é»À®Ê¬¡¤°øº¡¹ØÇã»þ̳ɬÁªÚ¤´±Êý¼øÜÞÄÌÏ©¡£

°ÂÁ´·úµÄ¡§

Í­¿´·ì´É°¿ËýÀ­¼ÀÉ ¢ª Í¥ÀèÅ·Á³ÁðËÜ產ÉÊ

·ò¹¯ÃËÀ­ ¢ª ¶ö¼¤²ÄÉþÍѰҼ©¹Ý¨ÚÃ





»Í¡¢Å¬ÍѲ·²çлÈÍÑ·úµÄ
°Ò¼©¹ÝŬ¹ç¡§

ËÖµ¯¸ùǽ¾ã㨡ÊED¡ËÃËÀ­

¼ûÍר¹ï½õËÖ¼Ô

¶ö¼¤À­À¸³è»ÈÍÑ

°ìßÜÅþŷμÔãÀµÉÊŬ¹ç¡§

ÁÛĹ´ü²þÁ±À­¸ùǽçÐñóǽ¼Ô

ÍÆ°×Áá±Ì°¿À­Èè˳¼Ô

ÁÛùᶯ»ýµ×ÎÏçм«¿®¼Ô

ÉôʬÃËÀ­ÐòºÎÍѡֺ®¹çºöά¡×¡§Ê¿»þÉþÍѰìßÜÅþŷμÀµÉÊÄ´Íýñó¼Á¡¤¼ûÍ×»þÅëÇÛ°Ò¼©¹ÝÀµÉÊãÅþ¨»þÚò̡¤·ÁÀ®¡Ö內Íܳ°½õ¡×ŪÒÖ½ÅÄó¾£Êý°Æ¡£

¸Þ¡¢Õó²Èë·óÚ¡§Úò̼è·è±÷¸Ä¿Íñó¼Á
¡ÔTaiwan Journal of Men¡Çs Health¡Õ»Ø½Ð¡¤ÔãÍÛé»ÚòÌçÐǯóô¡¢¿´Íý狀ÂÖ¡¢À¸³è½¬´·µÚ²Ù¼¤ÌØ¿åʿ̩ÀÚÁêïð¡£Ä¹´üßòÌë°¿ÔÚÎϲáÂ硤¨»È»ÈÍѰҼ©¹Ý¡¤Ìé²ÄǽÚòÌÍ­¸Â¡£¼©ÁðËÜÇÛÊýÇ¡°ìßÜÅþŷμ§²ÄÆ©²á²þÁ±âÐ酮ʬÈç¡¢ùᶯ·ìή¡¤Äó¾£ËÖµ¯¹ÅÅÙçлýµ×ÎÏ¡£





Ï»¡¢·ë¸ì¡§ÁªÚ¤ºÇŬ¹ç¼«¸ÊŪÊý°Æ
°Ò¼©¹Ý ¢ª ¨ÚýõËÖ¡¢Ã»´üÇúâ¤Î϶¯¡¤îÐÕÜëúÕéÍ­ÚÃ

°ìßÜÅþŷμÀµÉÊ ¢ª Å·Á³ÁðËÜ¡¢Ä¹´üÄó¾£À­Ç½ÎÏçÐñó¼Á·úµÄÃËÀ­º¬Ú¡¼«¿È¼ûµá¡¢·ò¹¯狀¶·µÚÀ­À¸³èÉÑΨÁªÚ¤產ÉÊ¡¤ÊÂ̳ɬ ¹ØÇãÀµÉÊ¡¢½å½ÛÑýÎÌ¡¤ºÍǽ¿¿ÀµÃ£Åþ¡Ö°ìßÜÅþŷμ¡¢¿®¿´ÞàÞà¡×ŪÚò̡£

Áêïð產ÉÊ¿äÁ¦¡§¶âïÓ͵éçèÎÏãÒÖÚÃÊÒ ùþÔ¢¹ÈËâ°Ò³ÊÙÇ¡ÊVIGORA ¡Ë¿å²ÌÌ£¸ýÍϾû°Ò 100mg ÀµÉʹá¹ÁÏ·ÃæîР°õÅÙ½ã¿Ê¸ýÀµÉÊÉ¬ÍøÒ¦Priligy(POXET-60)GOODMAN±¢è³ùáÂç´ÝgoodmanÈþÔ¢ºÔÍø»ÎCialis¸¶êæ¿Ê¸ý®ÚýõËÖ

±ä¿­閱즡§°ìßÜÅþŷμÉûºîÍÑÉ÷ðª²òÀÏ
 

¤³¤Î¥¹¥ì¥Ã¥É¡Ê°ìßÜÅþŷμÔãÍÛé» vs °Ò¼©¹Ý¡§哪¼ïÚò̹¹¶¯¡©¡Ë¤ËÅê¹Æ

[Åê¹Æµ­»ö¤Îºï½ü¥¬¥¤¥É¥é¥¤¥ó¤Ï¤³¤Á¤é¡ÊPDF¡Ë]

Âê̾
¥²¥¹¥È̾
Åê¹ÆËÜʸ
²èÁü¤ÎÅê¹Æ


°Ê²¼¡¢¤³¤Î¥µ¥¤¥È(¤ß¤ó¤Ê¤ÎÁ¥¶¶)¤Î¥æ¡¼¥¶ÍÑ¥á¥Ë¥å¡¼¤È¡¢ÅÐÏ¿¤µ¤ì¤¿Á¥¶¶ Çð »ÔÀî ½¬»ÖÌî ȬÀéÂå ¤Î´ë¶È¤ªÅ¹¾ðÊó¤Î¥«¥Æ¥´¥ê°ìÍ÷¤Ç¤¹¡£
¤³¤Î¥Ú¡¼¥¸¤ÎÀèÆ¬¤ØÌá¤ë

¤³¤ó¤Ë¤Á¤Ï¡ª
¥²¥¹¥È¤µ¤ó

¥²¥¹¥È¤µ¤ó